ID   P4HA3_HUMAN             Reviewed;         544 AA.
AC   Q7Z4N8; A0AV13; B4DUD3; Q5EBL3; Q5JPA9;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   28-JUN-2023, entry version 166.
DE   RecName: Full=Prolyl 4-hydroxylase subunit alpha-3;
DE            Short=4-PH alpha-3;
DE            EC=1.14.11.2 {ECO:0000269|PubMed:14500733};
DE   AltName: Full=Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3;
DE   Flags: Precursor;
GN   Name=P4HA3; ORFNames=UNQ711/PRO1374;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, TISSUE
RP   SPECIFICITY, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=14500733; DOI=10.1074/jbc.m306806200;
RA   Kukkola L., Hieta R., Kivirikko K.I., Myllyharju J.;
RT   "Identification and characterization of a third human, rat, and mouse
RT   collagen prolyl 4-hydroxylase isoenzyme.";
RL   J. Biol. Chem. 278:47685-47693(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Vascular smooth muscle;
RX   PubMed=12874193; DOI=10.1161/01.cir.0000080883.53863.5c;
RA   Van Den Diepstraten C., Papay K., Bolender Z., Brown A., Pickering J.G.;
RT   "Cloning of a novel prolyl 4-hydroxylase subunit expressed in the fibrous
RT   cap of human atherosclerotic plaque.";
RL   Circulation 108:508-511(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ASN-400.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes the post-translational formation of 4-
CC       hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other
CC       proteins. {ECO:0000269|PubMed:12874193, ECO:0000269|PubMed:14500733}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-prolyl-[collagen] + O2 = CO2 + succinate +
CC         trans-4-hydroxy-L-prolyl-[collagen]; Xref=Rhea:RHEA:18945, Rhea:RHEA-
CC         COMP:11676, Rhea:RHEA-COMP:11680, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:30031,
CC         ChEBI:CHEBI:50342, ChEBI:CHEBI:61965; EC=1.14.11.2;
CC         Evidence={ECO:0000269|PubMed:14500733};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18946;
CC         Evidence={ECO:0000305|PubMed:14500733};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000305|PubMed:14500733};
CC   -!- COFACTOR:
CC       Name=L-ascorbate; Xref=ChEBI:CHEBI:38290;
CC         Evidence={ECO:0000305|PubMed:14500733};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.5 uM for Fe(2+) {ECO:0000269|PubMed:14500733};
CC         KM=20 uM for 2-oxoglutarate {ECO:0000269|PubMed:14500733};
CC         KM=24 uM for (Pro-Pro-Gly) {ECO:0000269|PubMed:14500733};
CC         KM=370 uM for L-ascorbate {ECO:0000269|PubMed:14500733};
CC   -!- SUBUNIT: Heterotetramer of two alpha-3 chains and two beta chains (the
CC       beta chain is the multi-functional PDI). {ECO:0000269|PubMed:12874193,
CC       ECO:0000269|PubMed:14500733}.
CC   -!- INTERACTION:
CC       Q7Z4N8; O14734: ACOT8; NbExp=3; IntAct=EBI-10181968, EBI-1237371;
CC       Q7Z4N8; P18825: ADRA2C; NbExp=3; IntAct=EBI-10181968, EBI-12015266;
CC       Q7Z4N8; Q9NYG5-2: ANAPC11; NbExp=3; IntAct=EBI-10181968, EBI-12224467;
CC       Q7Z4N8; Q86V38: ATN1; NbExp=3; IntAct=EBI-10181968, EBI-11954292;
CC       Q7Z4N8; Q9BPU9: B9D2; NbExp=3; IntAct=EBI-10181968, EBI-6958971;
CC       Q7Z4N8; O95429: BAG4; NbExp=3; IntAct=EBI-10181968, EBI-2949658;
CC       Q7Z4N8; Q6QNY1: BLOC1S2; NbExp=3; IntAct=EBI-10181968, EBI-465872;
CC       Q7Z4N8; Q9NSG2: C1orf112; NbExp=3; IntAct=EBI-10181968, EBI-11128910;
CC       Q7Z4N8; Q9BXJ5: C1QTNF2; NbExp=3; IntAct=EBI-10181968, EBI-2817707;
CC       Q7Z4N8; Q5T4B2: CERCAM; NbExp=3; IntAct=EBI-10181968, EBI-12261896;
CC       Q7Z4N8; P17540: CKMT2; NbExp=3; IntAct=EBI-10181968, EBI-712973;
CC       Q7Z4N8; Q16740: CLPP; NbExp=3; IntAct=EBI-10181968, EBI-1056029;
CC       Q7Z4N8; Q8WUE5: CT55; NbExp=3; IntAct=EBI-10181968, EBI-6873363;
CC       Q7Z4N8; P78358: CTAG1B; NbExp=3; IntAct=EBI-10181968, EBI-1188472;
CC       Q7Z4N8; Q9NSA3: CTNNBIP1; NbExp=3; IntAct=EBI-10181968, EBI-747082;
CC       Q7Z4N8; Q96EV8: DTNBP1; NbExp=3; IntAct=EBI-10181968, EBI-465804;
CC       Q7Z4N8; Q96C01: FAM136A; NbExp=3; IntAct=EBI-10181968, EBI-373319;
CC       Q7Z4N8; Q9NZ52-2: GGA3; NbExp=3; IntAct=EBI-10181968, EBI-12075758;
CC       Q7Z4N8; Q9Y4H4: GPSM3; NbExp=3; IntAct=EBI-10181968, EBI-347538;
CC       Q7Z4N8; O14964: HGS; NbExp=6; IntAct=EBI-10181968, EBI-740220;
CC       Q7Z4N8; Q3LI72: KRTAP19-5; NbExp=3; IntAct=EBI-10181968, EBI-1048945;
CC       Q7Z4N8; Q3LI64: KRTAP6-1; NbExp=3; IntAct=EBI-10181968, EBI-12111050;
CC       Q7Z4N8; Q8IUC2: KRTAP8-1; NbExp=3; IntAct=EBI-10181968, EBI-10261141;
CC       Q7Z4N8; Q9P2M1: LRP2BP; NbExp=3; IntAct=EBI-10181968, EBI-18273118;
CC       Q7Z4N8; P43356: MAGEA2B; NbExp=4; IntAct=EBI-10181968, EBI-5650739;
CC       Q7Z4N8; Q96E03: MAGEA2B; NbExp=3; IntAct=EBI-10181968, EBI-10239285;
CC       Q7Z4N8; Q9UBF1: MAGEC2; NbExp=4; IntAct=EBI-10181968, EBI-5651487;
CC       Q7Z4N8; P59942: MCCD1; NbExp=3; IntAct=EBI-10181968, EBI-11987923;
CC       Q7Z4N8; P50222: MEOX2; NbExp=3; IntAct=EBI-10181968, EBI-748397;
CC       Q7Z4N8; Q9UJ68: MSRA; NbExp=3; IntAct=EBI-10181968, EBI-19157918;
CC       Q7Z4N8; A0A0S2Z3Y6: NDN; NbExp=3; IntAct=EBI-10181968, EBI-16435852;
CC       Q7Z4N8; A0A0S2Z442: NDN; NbExp=3; IntAct=EBI-10181968, EBI-16435864;
CC       Q7Z4N8; Q9BSH3: NICN1; NbExp=3; IntAct=EBI-10181968, EBI-13324229;
CC       Q7Z4N8; Q86Y26: NUTM1; NbExp=4; IntAct=EBI-10181968, EBI-10178410;
CC       Q7Z4N8; O43482: OIP5; NbExp=3; IntAct=EBI-10181968, EBI-536879;
CC       Q7Z4N8; O75360: PROP1; NbExp=3; IntAct=EBI-10181968, EBI-9027467;
CC       Q7Z4N8; P28070: PSMB4; NbExp=3; IntAct=EBI-10181968, EBI-603350;
CC       Q7Z4N8; Q9NWB1-5: RBFOX1; NbExp=3; IntAct=EBI-10181968, EBI-12123390;
CC       Q7Z4N8; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-10181968, EBI-6257312;
CC       Q7Z4N8; Q6ZMJ2-2: SCARA5; NbExp=3; IntAct=EBI-10181968, EBI-12823227;
CC       Q7Z4N8; Q53GC0: SERTAD1; NbExp=3; IntAct=EBI-10181968, EBI-2826300;
CC       Q7Z4N8; Q9UJW9: SERTAD3; NbExp=3; IntAct=EBI-10181968, EBI-748621;
CC       Q7Z4N8; Q9NZ72: STMN3; NbExp=3; IntAct=EBI-10181968, EBI-725557;
CC       Q7Z4N8; Q08117-2: TLE5; NbExp=3; IntAct=EBI-10181968, EBI-11741437;
CC       Q7Z4N8; Q96NM4-3: TOX2; NbExp=3; IntAct=EBI-10181968, EBI-12815137;
CC       Q7Z4N8; A5D8V6: VPS37C; NbExp=3; IntAct=EBI-10181968, EBI-2559305;
CC       Q7Z4N8; O43379: WDR62; NbExp=3; IntAct=EBI-10181968, EBI-714790;
CC       Q7Z4N8; O15156-2: ZBTB7B; NbExp=3; IntAct=EBI-10181968, EBI-11522250;
CC       Q7Z4N8; Q5D1E8: ZC3H12A; NbExp=6; IntAct=EBI-10181968, EBI-747793;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q7Z4N8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z4N8-2; Sequence=VSP_031146, VSP_031147;
CC       Name=3;
CC         IsoId=Q7Z4N8-3; Sequence=VSP_054131;
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta, liver and fetal skin.
CC       Weakly expressed in fetal epiphyseal cartilage, fetal liver,
CC       fibroblast, lung and skeletal muscle. Expressed also in fibrous cap of
CC       carotid atherosclerotic lesions. {ECO:0000269|PubMed:12874193,
CC       ECO:0000269|PubMed:14500733}.
CC   -!- PTM: N-glycosylation plays no role in the catalytic activity.
CC   -!- SIMILARITY: Belongs to the P4HA family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY313448; AAQ87603.1; -; mRNA.
DR   EMBL; AY327887; AAP97874.1; -; mRNA.
DR   EMBL; AY358521; AAQ88885.1; -; mRNA.
DR   EMBL; AK300598; BAG62295.1; -; mRNA.
DR   EMBL; AP000577; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001085; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL833965; CAI46215.1; -; mRNA.
DR   EMBL; CH471076; EAW74935.1; -; Genomic_DNA.
DR   EMBL; BC089446; AAH89446.1; -; mRNA.
DR   EMBL; BC117333; AAI17334.1; -; mRNA.
DR   EMBL; BC126170; AAI26171.1; -; mRNA.
DR   CCDS; CCDS73347.1; -. [Q7Z4N8-3]
DR   CCDS; CCDS8230.1; -. [Q7Z4N8-1]
DR   RefSeq; NP_001275677.1; NM_001288748.1. [Q7Z4N8-3]
DR   RefSeq; NP_878907.1; NM_182904.4. [Q7Z4N8-1]
DR   AlphaFoldDB; Q7Z4N8; -.
DR   SMR; Q7Z4N8; -.
DR   BioGRID; 129495; 142.
DR   CORUM; Q7Z4N8; -.
DR   IntAct; Q7Z4N8; 103.
DR   MINT; Q7Z4N8; -.
DR   STRING; 9606.ENSP00000401749; -.
DR   GlyCosmos; Q7Z4N8; 2 sites, No reported glycans.
DR   GlyGen; Q7Z4N8; 2 sites.
DR   iPTMnet; Q7Z4N8; -.
DR   PhosphoSitePlus; Q7Z4N8; -.
DR   BioMuta; P4HA3; -.
DR   DMDM; 74738714; -.
DR   MassIVE; Q7Z4N8; -.
DR   MaxQB; Q7Z4N8; -.
DR   PaxDb; Q7Z4N8; -.
DR   PeptideAtlas; Q7Z4N8; -.
DR   ProteomicsDB; 5178; -.
DR   ProteomicsDB; 69217; -. [Q7Z4N8-1]
DR   ProteomicsDB; 69218; -. [Q7Z4N8-2]
DR   Antibodypedia; 2002; 163 antibodies from 24 providers.
DR   DNASU; 283208; -.
DR   Ensembl; ENST00000331597.9; ENSP00000332170.4; ENSG00000149380.12. [Q7Z4N8-1]
DR   Ensembl; ENST00000427714.2; ENSP00000401749.2; ENSG00000149380.12. [Q7Z4N8-3]
DR   Ensembl; ENST00000524388.5; ENSP00000433860.1; ENSG00000149380.12. [Q7Z4N8-2]
DR   GeneID; 283208; -.
DR   KEGG; hsa:283208; -.
DR   MANE-Select; ENST00000331597.9; ENSP00000332170.4; NM_182904.5; NP_878907.1.
DR   UCSC; uc001ouz.5; human. [Q7Z4N8-1]
DR   AGR; HGNC:30135; -.
DR   CTD; 283208; -.
DR   DisGeNET; 283208; -.
DR   GeneCards; P4HA3; -.
DR   HGNC; HGNC:30135; P4HA3.
DR   HPA; ENSG00000149380; Tissue enhanced (smooth).
DR   MIM; 608987; gene.
DR   neXtProt; NX_Q7Z4N8; -.
DR   OpenTargets; ENSG00000149380; -.
DR   PharmGKB; PA134870931; -.
DR   VEuPathDB; HostDB:ENSG00000149380; -.
DR   eggNOG; KOG1591; Eukaryota.
DR   GeneTree; ENSGT00940000158967; -.
DR   HOGENOM; CLU_024155_0_0_1; -.
DR   InParanoid; Q7Z4N8; -.
DR   OMA; DVYMPAV; -.
DR   OrthoDB; 2899308at2759; -.
DR   PhylomeDB; Q7Z4N8; -.
DR   TreeFam; TF313393; -.
DR   BRENDA; 1.14.11.2; 2681.
DR   PathwayCommons; Q7Z4N8; -.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   SignaLink; Q7Z4N8; -.
DR   BioGRID-ORCS; 283208; 15 hits in 1152 CRISPR screens.
DR   ChiTaRS; P4HA3; human.
DR   GenomeRNAi; 283208; -.
DR   Pharos; Q7Z4N8; Tbio.
DR   PRO; PR:Q7Z4N8; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q7Z4N8; protein.
DR   Bgee; ENSG00000149380; Expressed in decidua and 134 other tissues.
DR   ExpressionAtlas; Q7Z4N8; baseline and differential.
DR   Genevisible; Q7Z4N8; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0004656; F:procollagen-proline 4-dioxygenase activity; IBA:GO_Central.
DR   GO; GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IBA:GO_Central.
DR   Gene3D; 6.10.140.1460; -; 1.
DR   Gene3D; 2.60.120.620; q2cbj1_9rhob like domain; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 1.
DR   InterPro; IPR005123; Oxoglu/Fe-dep_dioxygenase.
DR   InterPro; IPR045054; P4HA-like.
DR   InterPro; IPR006620; Pro_4_hyd_alph.
DR   InterPro; IPR044862; Pro_4_hyd_alph_FE2OG_OXY.
DR   InterPro; IPR013547; Pro_4_hyd_alph_N.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   PANTHER; PTHR10869; PROLYL 4-HYDROXYLASE ALPHA SUBUNIT; 1.
DR   PANTHER; PTHR10869:SF223; PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-3; 1.
DR   Pfam; PF13640; 2OG-FeII_Oxy_3; 1.
DR   Pfam; PF08336; P4Ha_N; 1.
DR   SMART; SM00702; P4Hc; 1.
DR   SUPFAM; SSF48452; TPR-like; 1.
DR   PROSITE; PS51471; FE2OG_OXY; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Dioxygenase; Endoplasmic reticulum;
KW   Glycoprotein; Iron; Metal-binding; Oxidoreductase; Reference proteome;
KW   Signal; TPR repeat; Vitamin C.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..544
FT                   /note="Prolyl 4-hydroxylase subunit alpha-3"
FT                   /id="PRO_0000317766"
FT   REPEAT          227..260
FT                   /note="TPR"
FT   DOMAIN          422..529
FT                   /note="Fe2OG dioxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   COILED          107..131
FT                   /evidence="ECO:0000255"
FT   BINDING         440
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         442
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         510
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         520
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   CARBOHYD        242
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        482
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         257
FT                   /note="S -> R (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_031146"
FT   VAR_SEQ         258..544
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_031147"
FT   VAR_SEQ         490..544
FT                   /note="NAALFWWNLHRSGEGDSDTLHAGCPVLVGDKWVANKWIHEYGQEFRRPCSSS
FT                   PED -> HCFGGTCTGVVKGTVTHFMLAVLSWWEISGWPTSGYMSMDRNSADPAAPALK
FT                   TELLAERSWWSPVAFQRSQEPKAGVGEEKAEQPPGRRPCQLCLCLANQRQGRGCYQGTL
FT                   RMYI (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054131"
FT   VARIANT         400
FT                   /note="D -> N (in dbSNP:rs2282488)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_038675"
FT   CONFLICT        222
FT                   /note="D -> Y (in Ref. 8; AAH89446)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   544 AA;  61126 MW;  1C88C168A268572F CRC64;
     MGPGARLAAL LAVLALGTGD PERAAARGDT FSALTSVARA LAPERRLLGL LRRYLRGEEA
     RLRDLTRFYD KVLSLHEDST TPVANPLLAF TLIKRLQSDW RNVVHSLEAS ENIRALKDGY
     EKVEQDLPAF EDLEGAARAL MRLQDVYMLN VKGLARGVFQ RVTGSAITDL YSPKRLFSLT
     GDDCFQVGKV AYDMGDYYHA IPWLEEAVSL FRGSYGEWKT EDEASLEDAL DHLAFAYFRA
     GNVSCALSLS REFLLYSPDN KRMARNVLKY ERLLAESPNH VVAEAVIQRP NIPHLQTRDT
     YEGLCQTLGS QPTLYQIPSL YCSYETNSNA YLLLQPIRKE VIHLEPYIAL YHDFVSDSEA
     QKIRELAEPW LQRSVVASGE KQLQVEYRIS KSAWLKDTVD PKLVTLNHRI AALTGLDVRP
     PYAEYLQVVN YGIGGHYEPH FDHATSPSSP LYRMKSGNRV ATFMIYLSSV EAGGATAFIY
     ANLSVPVVRN AALFWWNLHR SGEGDSDTLH AGCPVLVGDK WVANKWIHEY GQEFRRPCSS
     SPED
//
